← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:113 | 113 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1327 | 72934-1327-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4343 | 72934-4343-8 | Betamethasone Dipropionate; Minoxidil | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:113 | 113 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzyl Alcohol | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1582 | 72934-1582-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1580 | 72934-1580-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:114 | 114 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-216 | 70092-216-50 | Heparin 1 U/ml 50 ml NS syr PF | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:114 | 114 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amitriptyline Hydrochloride; Gabapentin; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2405 | 72627-2405-1 | Ascorbic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:114 | 114 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Asparaginase | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-101 | 73702-101-30 | Atropine | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:114 | 114 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:114 | 114 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-7272 | 72682-7272-3 | Ascorbic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9012 | 83826-9012-3 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1326 | 72934-1326-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4344 | 72934-4344-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1584 | 72934-1584-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:114 | 114 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1582 | 72934-1582-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:115 | 115 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2395 | 72934-2395-2 | Diooxia CReam | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:115 | 115 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amitriptyline Hydrochloride; Gabapentin; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:115 | 115 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0001 | 72196-0001-1 | Aspartic Acid; Glutamic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-935 | 69374-935-03 | Atropine | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:115 | 115 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-06 | Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-3 | Benzyl Alcohol | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:115 | 115 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1330 | 72934-1330-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4597 | 72934-4597-8 | Betamethasone Dipropionate; Minoxidil | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1580 | 72934-1580-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:115 | 115 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1584 | 72934-1584-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:116 | 116 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue 5mg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:116 | 116 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amitriptyline Hydrochloride; Gabapentin; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-06 | Atropine Sulfate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-1 | Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:116 | 116 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-2 | Benzyl Alcohol | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0001 | 72196-0001-1 | Aspartic Acid; Glutamic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:116 | 116 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1332 | 72934-1332-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4598 | 72934-4598-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1581 | 72934-1581-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:116 | 116 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1583 | 72934-1583-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:117 | 117 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0104 | 71285-0104-1 | Maintenance 4 to 1 Low K (36 mEq) Low Tromethamine 1000ml Bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:117 | 117 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ampicillin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:117 | 117 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:117 | 117 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-3 | Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-508 | 65302-508-03 | Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:117 | 117 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1329 | 72934-1329-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1583 | 72934-1583-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:117 | 117 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1581 | 72934-1581-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:118 | 118 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:118 | 118 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ampicillin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:118 | 118 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:118 | 118 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:118 | 118 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-3 | Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-2 | Betamethasone Sodium Phosphate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:118 | 118 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-173 | 70092-173-43 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-122 | 73177-122-01 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1328 | 72934-1328-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-22 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:118 | 118 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzyl Alcohol | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:118 | 118 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-113 | 73198-113-10 | Benzyl Alcohol | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:119 | 119 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1329 | 72934-1329-2 | Inzdeaxiatar Gel | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:119 | 119 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ampicillin Sodium; Sulbactam Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-690 | 72833-690-50 | Ascorbic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:119 | 119 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aspirin | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-1 | Atropine Sulfate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:119 | 119 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-1 | Betamethasone Sodium Phosphate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:119 | 119 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:119 | 119 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1331 | 72934-1331-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-90 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-2 | Betamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:119 | 119 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:120 | 120 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-505 | 81375-505-01 | Moxifloxacin SI | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ampicillin Sodium; Sulbactam Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atenolol | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzyl Alcohol | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:120 | 120 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4597 | 72934-4597-8 | Betamethasone Dipropionate; Minoxidil | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:120 | 120 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4597 | 72934-4597-8 | Betamethasone Dipropionate; Minoxidil | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:121 | 121 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-04 | Fentanyl Citrate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0410 | 70168-0410-1 | Anastrozole | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:121 | 121 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Asparaginase | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:121 | 121 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atenolol | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:121 | 121 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:121 | 121 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:121 | 121 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-98 | Bevacizumab | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:121 | 121 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0101 | 83556-0101-1 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4598 | 72934-4598-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:121 | 121 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4598 | 72934-4598-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:122 | 122 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-51 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0440 | 70168-0440-1 | Anastrozole | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-935 | 69374-935-03 | Atropine | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4343 | 72934-4343-8 | Betamethasone Dipropionate; Minoxidil | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:122 | 122 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:122 | 122 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-2 | Betamethasone Sodium Phosphate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:123 | 123 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2548 | 72934-2548-2 | Dynoma | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0430 | 70168-0430-1 | Anastrozole | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0001 | 72196-0001-1 | Aspartic Acid; Glutamic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:123 | 123 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:123 | 123 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:123 | 123 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:123 | 123 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-06 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:123 | 123 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4350 | 72934-4350-8 | Betamethasone Dipropionate; Minoxidil | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:123 | 123 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-99 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:123 | 123 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-99 | Bevacizumab | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:124 | 124 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-104 | 73198-104-30 | Tri-Immune Boost | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-1004 | 71138-1004-1 | Anastrozole; 1-Testosterone | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:124 | 124 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:124 | 124 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:124 | 124 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:124 | 124 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:124 | 124 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-182 | 63037-182-25 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4344 | 72934-4344-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-2 | Betamethasone Sodium Phosphate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:124 | 124 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-90 | Bevacizumab | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:125 | 125 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1551 | 72934-1551-2 | Teliora | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0754 | 71138-0754-1 | Anastrozole; Testosterone | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-935 | 69374-935-03 | Atropine | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-06 | Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-707 | 72833-707-02 | Avexitide | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:125 | 125 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3160 | 72627-3160-1 | Azelaic Acid; Hydroquinone; Tretinoin | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:125 | 125 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:125 | 125 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6635 | 71300-6635-2 | Baclofen | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-1 | Betamethasone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-343 | 69194-343-01 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-22 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-99 | Bevacizumab | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:125 | 125 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:126 | 126 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-049 | 68985-049-91 | Phenylephrine 1MG | 2024-2 | valid | 0 | 2026-09-18 |